Two Creeks Capital Management LP boosted its holdings in shares of Rentokil Initial PLC (NYSE:RTO – Free Report) by 325.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 338,678 shares of the company’s stock after buying an additional 259,088 shares during the period. Rentokil Initial comprises 0.6% of Two Creeks Capital Management LP’s portfolio, making the stock its 24th largest holding. Two Creeks Capital Management LP owned approximately 0.07% of Rentokil Initial worth $8,552,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Independent Franchise Partners LLP boosted its holdings in Rentokil Initial by 662.2% during the third quarter. Independent Franchise Partners LLP now owns 778,628 shares of the company’s stock valued at $19,660,000 after purchasing an additional 676,473 shares in the last quarter. Brown Brothers Harriman & Co. raised its holdings in shares of Rentokil Initial by 98.2% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 63,091 shares of the company’s stock worth $1,593,000 after buying an additional 31,258 shares in the last quarter. Broyhill Asset Management LLC lifted its position in shares of Rentokil Initial by 33.5% during the 3rd quarter. Broyhill Asset Management LLC now owns 118,455 shares of the company’s stock worth $2,991,000 after buying an additional 29,714 shares during the period. UBS Group AG lifted its position in shares of Rentokil Initial by 124.4% during the 3rd quarter. UBS Group AG now owns 486,396 shares of the company’s stock worth $12,281,000 after buying an additional 269,676 shares during the period. Finally, BNP Paribas Financial Markets boosted its stake in Rentokil Initial by 12,500,000.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 250,002 shares of the company’s stock valued at $6,313,000 after buying an additional 250,000 shares in the last quarter. Institutional investors own 9.91% of the company’s stock.
Rentokil Initial Price Performance
RTO opened at $32.33 on Friday. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.12 and a quick ratio of 1.03. The company’s 50 day simple moving average is $31.56 and its 200-day simple moving average is $28.59. Rentokil Initial PLC has a one year low of $19.60 and a one year high of $33.47.
Rentokil Initial Announces Dividend
Wall Street Analyst Weigh In
Several research analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft lowered Rentokil Initial from a “buy” rating to a “hold” rating in a research note on Tuesday, February 24th. Oppenheimer boosted their target price on shares of Rentokil Initial from $30.00 to $35.00 and gave the company an “outperform” rating in a research note on Tuesday. UBS Group upgraded shares of Rentokil Initial from a “neutral” rating to a “buy” rating in a research report on Thursday. JPMorgan Chase & Co. reissued an “overweight” rating on shares of Rentokil Initial in a report on Friday, November 21st. Finally, Rothschild & Co Redburn upgraded shares of Rentokil Initial from a “sell” rating to a “neutral” rating in a research report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $34.50.
Read Our Latest Stock Analysis on RTO
Rentokil Initial Profile
Rentokil Initial PLC is a global business services company specializing in pest control, hygiene and workwear services. Headquartered in Crawley, West Sussex, United Kingdom, the company delivers outsourced solutions designed to protect people, preserve assets and enhance workplaces for both commercial and residential customers.
Under the Rentokil Pest Control brand, the company offers services ranging from routine inspections and treatment of insects, rodents and birds to specialised programmes for food manufacturing and healthcare environments.
Further Reading
- Five stocks we like better than Rentokil Initial
- A personal warning from Martin Weiss (Please read)
- Forget oil — this changes everything about American energy…
- $30 stock to buy before Starlink goes public (WATCH NOW!)
- This coin has everything going for it
- Only 500 people today…
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.
